Peripheral T-cell lymphoma: Review and updates of current management strategies

• Main Authors: Lim, S.T, Tang, T, Tay, K, Quek, R, Tao, M, Tan, S.Y, Tan, L
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Review
• Published: Hindawi 2020
• Subjects: alemtuzumab; bleomycin; cyclophosphamide; cytarabine; denileukin diftitox; dexamethasone; doxorubicin; etoposide; fluorodeoxyglucose; gemcitabine; histone deacetylase inhibitor; methotrexate; pralatrexate; prednisolone; romidepsin; vincristine; vorinostat; add on therapy; allogeneic stem cell transplantation; apoptosis; autologous stem cell transplantation; B cell lymphoma; cancer combination chemotherapy; cancer incidence; cancer patient; cancer regression; cancer risk; cancer therapy; clinical assessment; clinical trial (topic); computer assisted emission tomography; computer assisted tomography; cutaneous T cell lymphoma; cytomegalovirus infection; disease severity; drug dose increase; drug fatality; epidemiological data; event free survival; gene expression profiling; graft versus host reaction; histopathology; human; immunohistochemistry; immunophenotyping; infection; invasive aspergillosis; JC virus encephalopathy; laboratory test; multicenter study (topic); multiple cycle treatment; neutropenia; NK T cell lymphoma; overall survival; peripheral T cell lymphoma; physical examination; Pneumocystis pneumonia; positron emission tomography; priority journal; prognosis; progression free survival; prospective study; review; risk factor; stem cell transplantation; T cell lymphoma; treatment response; tuberculosis; virus pneumonia; virus retinitis
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/178192
• Institution: National University of Singapore

10.1155/2010/624040